Teratogenic Effects of Chronic Treatment with Corticosterone on Tadpoles of Xenopus laevis

Chronic Exposure to Two Gestagens Differentially Alters Morphology and Gene Expression in Silurana tropicalis

Gestagens are active ingredients in human and veterinary drugs with progestogenic activity. Two gestagens-progesterone (P4), and the synthetic P4 analogue, melengestrol acetate (MGA)-are approved for use in beef cattle agriculture in North America. Both P4 and MGA have been measured in surface water receiving runoff from animal agricultural operations. This project aimed to assess the morphometric and molecular consequences of chronic exposures to P4, MGA, and their mixture during Western clawed frog metamorphosis. Chronic exposure (from embryo to metamorphosis) to MGA (1.7 µg/L) or P4 + MGA (0.22 µg/L P4 + 1.5 µg/L MGA) caused a considerable dysregulation of metamorphic timing, as evidenced by an inhibition of growth, narrower head, and lack of forelimb emergence in all animals. Molecular analysis revealed that chronic exposure to the mixture induced an additive upregulation of neurosteroid-related (GABA_A receptor subunit α6 (gabra6) and steroid 5-alpha reductase 1 (srd5α1) gene expression in brain tissue. Chronic P4 exposure (0.26 µg/L P4) induced a significant upregulation of the expression hypothalamic-pituitary-gonadal (HPG)-related genes (ipgr, erα) in the gonadal mesonephros complex (GMC). Our data suggest that exposure to P4, MGA, and their mixture induces multiple endocrine responses and adverse effects in larval Western clawed frogs. This study helps to better our understanding of the consequences of chronic gestagen exposure and suggests that the implications and risk of high gestagen use in beef cattle feeding operations may extend to the aquatic environment.

Effect of ethylenethiourea on metamorphosis and ovary development: A comparative study of three larval frogs

Amphibian endocrine systems interact with each other during normal development. Interference with one of the endocrine systems may influence others. We studied the effect of a thyroid inhibitor (ethylenethiourea [ETU]) on metamorphosis and ovary development of three species, Sphaerotheca pashchima, Indosylvirana caesari, and Euphlyctis cyanophlyctis with different larval durations. We treated the tadpoles of these species with 50, 100, and 200 mg/L concentrations of ETU and studied their larval duration, size at metamorphosis, and ovary development. The results revealed that ETU affects metamorphosis, depending on the species and concentration. ETU delayed metamorphosis of E. cyanophlyctis tadpoles and did not affect metamorphosis in S. pashchima tadpoles. Lower concentrations of ETU stimulated metamorphosis in I. caesari tadpoles while high concentration delayed metamorphosis. In the tadpoles (E. cyanophlyctis) treated with higher concentrations of ETU, ovary development was advanced with an increased size of the diplotene oocytes. Oocyte size was smaller in the tadpoles (of I. caesari) treated with lower concentrations of ETU. These results demonstrated that the tadpoles of these species show different responses to the thyroid inhibitor, possibly due to the differences in the larval duration and sensitivity. Inhibition or acceleration of metamorphosis did not interfere in the ovary development of E. cyanophlyctis and I. caesari. These results will be useful in understanding the impact of endocrine disruptors on the interaction between thyroid and sex steroid hormones.

Corticosteroids disrupt amphibian metamorphosis by complex modes of action including increased prolactin expression

Although thyroid hormones (TH) are the primary morphogens regulating amphibian metamorphosis, other hormones including corticosteroids are known to participate in this regulation. The present study investigated effects of corticosteroids on larval development of the amphibian Xenopus laevis. Premetamorphic tadpoles (stage 51) were treated with aldosterone (ALDO; 100 nM), corticosterone (B; 10, 100, 500 nM) and dexamethasone (DEX; 10, 100, 500 nM) for 21 days and organismal responses were assessed by gross morphology determining stage development, whole body length (WBL), and hind limb length (HLL). B and DEX reduced WBL and HLL and caused abnormal development including the lack of fore limb emergence while ALDO treatment showed no significant effect. Gene expression analyses using RT-PCR revealed up-regulation of prolactin (PRL) in brain, but down-regulation of type III deiodinase in tail tissue induced by the glucocorticoids B and DEX. Additionally, stromelysin-3 transcript in tail tissue was decreased by B. ALDO at 100 nM had no effect on mRNA expression, neither in brain nor in tail tissue. These findings indicate that corticosteroids modulate TH-dependent metamorphosis by complex mechanisms that even include indirect effects triggered by increased PRL mRNA expression.